Company intelligence / Profile preview

AAIPharma

Wilmington, North Carolina, USApitchbook.com ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

AAIPharma does not have its own clinical results or proprietary pipeline. It supports client programs across all stages of development from pre-clinical to commercial supply.

Therapeutic areas: OncologyOther
Modalities: Small moleculeBiologicMonoclonal antibodyVaccine
Industry: Contract Manufacturing Organization

Drug pipeline

3 assets

propoxyphene

Commercial

Indications: Pain

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on AAIPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAIPharma.

Explore the full profile